Dr. Cynthia L. Verst has been named Global Head of Late Phase Operations at Quintiles. In this role, she will leads the company’s dedicated business that bridges the gap between peri-approval and commercialization of marketed therapies. “Dr. Verst brings a dynamic leadership style and record of success in establishing and growing Late Phase operations,” said John Ratliff, Quintiles’ president and chief operating officer. “Biopharma companies have traditionally designed studies with a focus on ...